[1]
M. F. Bahrudin, T. Sarvanandan, and N. K. Y. Hee, “PEMBROLIZUMAB-INDUCED HYPOPHYSITIS WITH CENTRAL DIABETES INSIPIDUS: A RARE IMMUNE-MEDIATED ADVERSE EVENT”, J ASEAN Fed Endocr Soc, vol. 40, no. S1, pp. 29–30, May 2025.